Naoki Kanomata
- Oncology top 5%
- HER2/EGFR in Cancer Research 9
- Cancer Research top 5%
- Breast Cancer Treatment Studies 10
-
- Prostate Cancer Diagnosis and Treatment 9
- Prostate Cancer Treatment and Research 9
- Metastasis and carcinoma case studies 8
- Genetics top 10%
-
- Breast Lesions and Carcinomas 14
-
- Salivary Gland Tumors Diagnosis and Treatment 8
-
- Cancer and Skin Lesions 8
- Co-authors
- Takuya MoriyaAtsushi OchiaiTakahiro HasebeJunichi KurebayashiYoshiyuki MiyajiYuji KozukaTsutomu TamadaTeruki Sone
- Journals
- SHILAP Revista de lepidopterología (2 papers)PLoS ONE (2 papers)Cancer (3 papers)
- Partner nations
- JapanUnited StatesHong Kong
In The Last Decade
Naoki Kanomata
100 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 83
- Oncology 840
- Cancer Research 337
- Pulmonary and Respiratory Medicine 528
- Genetics 131
- Radiology, Nuclear Medicine and Imaging 246
Countries citing papers authored by Naoki Kanomata
This map shows the geographic impact of Naoki Kanomata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naoki Kanomata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naoki Kanomata more than expected).
Fields of papers citing papers by Naoki Kanomata
This network shows the impact of papers produced by Naoki Kanomata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naoki Kanomata. The network helps show where Naoki Kanomata may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Naoki Kanomata, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2023 | 1 | |
| 3 | 2022 | 1 | |
| 4 | 2022 | 2 | |
| 5 | 2022 | 4 | |
| 6 | 2021 | 5 | |
| 7 | 2021 | 2 | |
| 8 | 2019 | 15 | |
| 9 | 2018 | 10 | |
| 10 | 2017 | 39 | |
| 11 | 2016 | 26 | |
| 12 | 2015 | 27 | |
| 13 | 2014 | 60 | |
| 14 | 2012 | 66 | |
| 15 | Two cases of spindle cell carcinoma of the breast – Usefulness of immunohistochemical analysis | 2012 | 1 |
| 16 | 2012 | 108 | |
| 17 | 2007 | 14 | |
| 18 | 2004 | 1 | |
| 19 | 2004 | 16 | |
| 20 | 2001 | 30 |
About Naoki Kanomata
Naoki Kanomata is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 104 papers that have together received 1.7k indexed citations. Recurring topics across this work include Breast Lesions and Carcinomas (14 papers), Breast Cancer Treatment Studies (10 papers), Prostate Cancer Diagnosis and Treatment (9 papers), HER2/EGFR in Cancer Research (9 papers), Prostate Cancer Treatment and Research (9 papers), Metastasis and carcinoma case studies (8 papers), Salivary Gland Tumors Diagnosis and Treatment (8 papers) and Cancer and Skin Lesions (8 papers). The work is most often cited by research in Oncology (840 citations), Cancer Research (337 citations) and Pulmonary and Respiratory Medicine (528 citations). Naoki Kanomata has collaborated with scholars based in Japan, United States and Hong Kong. Frequent co-authors include Takuya Moriya, Atsushi Ochiai, Takahiro Hasebe, Junichi Kurebayashi, Yoshiyuki Miyaji, Yuji Kozuka, Tsutomu Tamada, Teruki Sone, Akira Yamamoto and Hiroyuki Yonou. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.